SEC Form 4 · accession 0001708138-18-000013
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Roy Vagelos
Officer — Chairman of the Board · Director
Period of report
Jul 9, 2018
Accepted (ET)
Jul 11, 2018 · 4:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 9, 2018 | M | 153,274 | $16.80 | A | 553,121 | D | |
| Common Stock | Jul 9, 2018 | F | 78,604 | $370.52 | D | 474,517 | D | |
| Common StockF2 | Jul 10, 2018 | S | 900 | $364.75 | D | 473,617 | D | |
| Common StockF3 | Jul 10, 2018 | S | 17,221 | $365.56 | D | 456,396 | D | |
| Common StockF4 | Jul 10, 2018 | S | 24,339 | $366.49 | D | 432,057 | D | |
| Common StockF5 | Jul 10, 2018 | S | 6,405 | $367.40 | D | 425,652 | D | |
| Common StockF6 | Jul 10, 2018 | S | 12,211 | $368.61 | D | 413,441 | D | |
| Common StockF7 | Jul 10, 2018 | S | 13,194 | $369.41 | D | 400,247 | D | |
| Common Stock | Jul 10, 2018 | S | 100 | $370.17 | D | 400,147 | D | |
| Common StockF8 | Jul 10, 2018 | S | 300 | $371.29 | D | 399,847 | D | |
| Common Stock | Jul 6, 2018 | G | 610 | $0.00 | D | 147,934 | I | by CLAT |
| Common Stock | holding | — | — | — | 2,310 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 83,652 | I | by Spouse as Trustee | |
| Common StockF9 | holding | — | — | — | 1,203 | I | by trust for grandch |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F10 | $16.80 | Jul 9, 2018 | M | 153,274 | D | — | Dec 17, 2018 | Common Stock | 153,274 | 0 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F10The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F2Represents volume-weighted average price of sales of 900 shares of Company stock on July 10, 2018 at prices ranging from $364.73 to $364.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F3Represents volume-weighted average price of sales of 17,221 shares of Company stock on July 10, 2018 at prices ranging from $365.05 to $365.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F4Represents volume-weighted average price of sales of 24,339 shares of Company stock on July 10, 2018 at prices ranging from $366.00 to $366.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F5Represents volume-weighted average price of sales of 6,405 shares of Company stock on July 10, 2018 at prices ranging from $367.02 to $367.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F6Represents volume-weighted average price of sales of 12,211 shares of Company stock on July 10, 2018 at prices ranging from $368.01 to $368.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F7Represents volume-weighted average price of sales of 13,194 shares of Company stock on July 10, 2018 at prices ranging from $369.00 to $369.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F8Represents volume-weighted average price of sales of 300 shares of Company stock on July 10, 2018 at prices ranging from $371.28 to $371.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 10, 2018 at each separate price.
- F9By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.